本页面由Tiger Trade Technology Pte. Ltd.提供服务

Senti Biosciences, Inc.

0.3300
+0.00702.17%
盘后:0.33000.00000.00%19:19 EDT
成交量:33.07万
成交额:10.96万
市值:1,027.77万
市盈率:-0.19
高:0.3500
开:0.3131
低:0.3130
收:0.3230
52周最高:2.88
52周最低:0.2900
股本:3,114.45万
流通股本:1,457.74万
量比:1.17
换手率:2.27%
股息:- -
股息率:- -
每股收益(TTM):-1.7136
每股收益(LYR):-2.7326
净资产收益率:-466.46%
总资产收益率:-65.57%
市净率:-3.02
市盈率(LYR):-0.12

数据加载中...

2026/09/24

重要事件披露

Form 8-K - Current report
2026/09/04

重要事件披露

Form 8-K - Current report
2026/09/03

重要事件披露

Form 8-K - Current report
2026/08/20

重要事件披露

Form 8-K - Current report
2026/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/15

重要事件披露

Form 8-K - Current report
2026/05/26

重要事件披露

Form 8-K - Current report
2026/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/14

重要事件披露

Form 8-K - Current report
2026/05/01

重要事件披露

Form 8-K - Current report
2026/04/30

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2026/04/24

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/04/24

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/04/24

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/04/24

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/04/24

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/04/01

重要事件披露

Form 8-K - Current report
2026/03/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/27

重要事件披露

Form 8-K - Current report
2026/03/19

重要事件披露

Form 8-K - Current report